GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ananda Developments PLC (AQSE:ANA) » Definitions » EBIT per Share

Ananda Developments (AQSE:ANA) EBIT per Share : £-0.00 (TTM As of Jul. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Ananda Developments EBIT per Share?

Ananda Developments's EBIT per Share for the six months ended in Jul. 2023 was £0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Jul. 2023 was £-0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Ananda Developments's EBIT per Share or its related term are showing as below:

AQSE:ANA's 3-Year EBIT Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.3
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Ananda Developments's EBIT for the six months ended in Jul. 2023 was £-0.95 Mil.


Ananda Developments EBIT per Share Historical Data

The historical data trend for Ananda Developments's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ananda Developments EBIT per Share Chart

Ananda Developments Annual Data
Trend Jan19 Jan20 Jan21 Jan22 Jan23
EBIT per Share
- - - - -

Ananda Developments Semi-Annual Data
Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Ananda Developments EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Ananda Developments's EBIT per Share for the fiscal year that ended in Jan. 2023 is calculated as

EBIT per Share(A: Jan. 2023 )
=EBIT/Shares Outstanding (Diluted Average)
=-1.053/850.991
=-0.00

Ananda Developments's EBIT per Share for the quarter that ended in Jul. 2023 is calculated as

EBIT per Share(Q: Jul. 2023 )
=EBIT/Shares Outstanding (Diluted Average)
=-0.945/2873.847
=-0.00

EBIT per Share for the trailing twelve months (TTM) ended in Jul. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ananda Developments  (AQSE:ANA) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.


Ananda Developments EBIT per Share Related Terms

Thank you for viewing the detailed overview of Ananda Developments's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Ananda Developments (AQSE:ANA) Business Description

Traded in Other Exchanges
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Ananda Developments PLC provides investment to healthcare market for the companies that develop medicinal or therapeutic cannabis derivatives, or related products including nutraceuticals, dietary supplements, and cosmetic products which contain Cannabis or hemp derived cannabinoids.

Ananda Developments (AQSE:ANA) Headlines

No Headlines